Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility.

Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. · 2014

Read Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. by Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4229860.txt.

Introduction

Chanchal Sur Chowdhury, Paul Hasler, and four co-authors studied neutrophil traps in rheumatoid arthritis in Arthritis Research and Therapy in 2014. Neutrophils can kill germs by throwing out webs of their own DNA, called extracellular traps. The same webs, loaded with proteins the immune system attacks in rheumatoid arthritis, might feed the disease.

Neutrophils from patients with active disease formed traps spontaneously far more than control cells. Their trap machinery ran hot at every step checked, from reactive oxygen output to the enzyme PAD4 moving into the nucleus and tagging histones. Patient antibodies proved necessary: removing IgG from serum stopped trap formation, and only antibody-positive IgG restored it. Trap debris in blood separated patients from controls well enough to suggest a diagnostic test.

Catalog record

CREATORSur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4229860

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility By Chanchal Sur Chowdhury, Stavros Giaglis, Ulrich A Walker, Andreas Buser, Sinuhe Hahn, Paul Hasler Published in: Arthritis Research & Therapy DOI: 10.1186/ar4579 ABSTRACT Introduction Neutrophil extracellular traps (NETs) have recently been implicated in a number of autoimmune conditions, including rheumatoid arthritis (RA). We examined the underlying signaling pathways triggering enhanced NETosis in RA and ascertained whether the products of NETosis had diagnostic implications or usefulness. Methods Neutrophils were isolated from RA patients with active disease and from controls. Spontaneous NET formation from RA and control neutrophils was assessed in vitro with microscopy and enzyme-linked immunosorbent assay (ELISA) for NETosis-derived products. The analysis of the signal-transduction cascade included reactive oxygen species (ROS) production, myeloperoxidase (MPO), neutrophil elastase (NE), peptidyl arginine deiminase 4 (PAD4), and citrullinated histone 3 (citH3). NET formation was studied in response to serum and synovial fluid and immunoglobulin G (IgG) depleted and reconstituted serum. Serum was analyzed for NETosis-derived products, for which receiver operator characteristic (ROC) curves were calculated. Results Neutrophils from RA cases exhibited increased spontaneous NET formation in vitro, associated with elevated ROS production, enhanced NE and MPO expression, nuclear translocation of PAD4, PAD4-mediated citrullination of H3, and altered nuclear morphology. NET formation in both anti-citrullinated peptide antibody (ACPA)-positive and -negative RA was abolished by IgG depletion, but restored only with ACPA-positive IgG. NETosis-derived products in RA serum demonstrated diagnostic potential, the ROC area under the curve for cell-free nucleosomes being >97%, with a sensitivity of 91% and a specificity of 92%. No significant difference was observed between ACPA-positive and -negative cases. Conclusions Signaling elements associated with the extrusion of NETs are significantly enhanced to promote NETosis in RA compared with healthy controls. NETosis depended on the presence of ACPA in ACPA-positive RA serum. The quantitation of NETosis-derived products, such as cell-free nucleosomes in serum, may be a useful complementary tool to discriminate between healthy controls and RA cases. INTRODUCTION A novel feature of the biology of polymorphonuclear granulocytes (PMNs) is their ability to generate neutrophil extracellular traps (NETs) [1] via a distinct process of cell death termed NETosis [2]. NETs consist of extruded chromosomal DNA decorated with granular components that include antimicrobial peptides and proteases. The molecular pathways leading to NETosis encompass calcium mobilization, generation of reactive oxygen species (ROS), nuclear delobulation involving the enzymatic activities of myeloperoxidase (MPO) and neutrophil elastase (NE), and chromatin modification via the citrullination of histones by peptidyl arginine deiminase 4 (PAD4) [2-6]. A number of studies have implicated NETs in the etiology of autoinflammatory or autoimmune conditions such as preeclampsia, Felty syndrome, systemic lupus erythematosus (SLE), multiple sclerosis, and, most recently, rheumatoid arthritis (RA) [7-13]. In the context of RA, these findings are especially interesting, as NETs have been proposed to contribute to the generation of anti-citrullinated protein antibody (ACPA) autoantigens, and may also be a target for autoantibodies [13,14]. PMNs isolated from RA patients showed an increased propensity to undergo spontaneous and LPS-induced NETosis, which was in part mediated by TNF and IL-17 and could be inhibited by blocking NADPH oxidase or PAD4. Whereas the citrullinated autoantigens vimentin and α-enolase were expressed on NETs from RA PMNs, antibodies to the former were able to induce NET formation by healthy control PMNs [13,14]. As we had previously detected significantly increased concentrations of cell-free DNA in the sera of RA patients compared with healthy controls, we were intrigued whether the provenance of this material involved NETosis [15]. The premise for the current investigation was that a link between circulating cell-free DNA levels and NETs has previously been made in a number of conditions, including preeclampsia, sepsis, cancer, thrombosis, or even storage of blood-transfusion products [16-19]. In view of these findings and reports on the complex involvement of neutrophil NETs in autoimmunity, we sought to investigate the NETotic response of PMNs in RA, with particular regard to the underlying signal-transduction cascade, and whether the products of overt NETosis could be diagnostically useful. MATERIALS AND METHODS Human subjects All patients fulfilled the American College of Rheumatology classification criteria for RA, or for systemic lupus erythematosus, respectively. Healthy volunteers, matched for gender and age, were recruited at the hospitals or at the Blood Bank of the Swiss Red Cross, Basel. Inclusion criteria for healthy controls were fair general condition, age ≥28 and ≤70 years, and for blood donors fulfilling national criteria for blood donation. Exclusion criteria were current or previous systemic autoimmune disease, asthma and reconvalescence after major illness, surgery, current medication with corticosteroids, immunosuppressive agents, and malignant neoplasia or chemotherapy within 5 years before recruitment for the study. RA cases had a DAS ≥2.6, were from age ≥27 to ≤70 years, and had no other systemic autoimmune disease, including ankylosing spondylitis and psoriatic arthritis. Exclusion criteria were corticosteroids ≥40 mg equivalent of prednisone daily, and those mentioned earlier for healthy controls. Informed, written consent was obtained from all subjects in the study, which was approved by the Cantonal Ethical Review Boards of Aargau-Solothurn and Basel/Basel-Land, Switzerland. Preparation of plasma and serum Plasma and serum were collected and processed as described previously [15]. Samples were studied immediately or stored at -80°C until analysis. Cell isolation PMNs were isolated with Dextran-Ficoll density centrifugation [8]. Cell viability was 96% to 98%, with a purity of >95% PMNs. Neutrophils seeded in 24-well plates were allowed to settle for 1 hour at 37°C under 5% CO2 before further experimentation. Cell-free DNA isolation and quantification Cell-free DNA extracted from 850 μl plasma or serum by using the QIAamp Circulating Nucleic Acid Kit (Qiagen, Valencia, CA, USA) was quantified by TaqMan real-time PCR (StepOne Plus Real-Time PCR System, Applied Biosystems, Foster City, CA, USA) specific for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene [15]. Detection of neutrophil elastase (NE), myeloperoxidase (MPO), and cell-free nucleosomes The concentrations of neutrophil elastase (NE) and myeloperoxidase (MPO) were measured with sandwich ELISA (Elastase/a1-PI Complex ELISA Kit, Calbiochem/EMD, Gibbstown, NJ, USA) and the human (MPO ELISA Kit, Hycult Biotech, Plymouth Meeting, PA, USA) respectively. Nucleosomes were measured by using the Human Cell Death Detection ELISAPLUS (Roche Diagnostics, Basel, Switzerland). Cell-culture supernatants were incubated with DNaseI (10 U for 5 minutes) (Roche Diagnostics) before analysis [20]. MPO/DNA complex detection MPO is present on extruded NETs. To detect such structures, NET-associated MPO/DNA complexes were quantified by using a modified capture ELISA [21]. In brief, NET-associated MPO in serum or culture supernatant was captured by using the coated 96-well plate of the human MPO ELISA Kit, (Hycult Biotech), after which the NET-associated DNA backbone was detected by using the detection antibody of the Human Cell Death Detection ELISAPLUS (Roche Diagnostics). PAD4/DNA-complex detection To detect the presence of PAD4 on extruded NETs in culture supernatants after spontaneous NETosis, cell-free PAD4/DNA complexes were quantified by using a modified capture ELISA, akin to that described for MPO earlier. In brief, cell-free PAD4 was captured by using the coated 96-well plate of a commercial human PAD4 ELISA (USCN Life Science, Inc., Wuhan, China), and associated DNA was detected by using Human Cell Death Detection ELISAPLUS kit (Roche Diagnostics). ROS generation analysis ROS was measured by using a 2′,7′-dichloro dihydrofluorescein diacetate (DCFH-DA) assay [22]. The

Read the complete text